BTIG analyst Yun Zhong downgrades Avrobio (NASDAQ:AVRO) from Buy to Neutral.
Morgan Stanley Upgrades Envista Holdings to Overweight, Announces $48 Price Target
Morgan Stanley analyst Drew Ranieri upgrades Envista Holdings (NYSE:NVST) from Equal-Weight to Overweight and announces $48 price target.